Access to Drugs and Reimbursement Under the New Medicare Programs G. Lawrence Atkins, Ph.D. Senior Director of Public Policy and Reimbursement SCHERING-PLOUGH CORPORATIONStanding Down The Sales Force Arms Race: Effect on Corporate Profitability Stefan Loren, Ph.D. Managing Director LEGG MASON The Pharmaceutical Industry Approval Rating Has Fallen to the Depths of Big Oil and Tobacco: What To Do About It Mike Pucci Vice President, External Advocacy Federal Affairs Group GLAXOSMITHKLINE The Medicare Modernization Act: Implications for Implementation for the Pharmaceutical Marketer Dolly A. Judge Senior Director, Federal Relations PFIZER, INC. New Designs on How to Play and Win in Managed Care Dexter W. Shurney, MD, MBA, MPH Chief Strategist Managed Markets AMGEN, INC. Launching a Biotech Drug in Today's Marketplace Martin Babler Vice President Sales and Marketing GENENTECH, INC. Global Marketing and Direct Sales Development Strategies for the US & Europe Mike Inouye Senior Vice President, Commercial Operations GILEAD SCIENCES
|